Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Mesothelioma, Malignant 5Hepatoblastoma 5Ototoxicity 4Medulloblastoma 4Central Nervous System Neoplasms 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Hearing Loss 3Gastrointestinal Neoplasms 3Drug-Related Side Effects and Adverse Reactions 3Testicular Neoplasms 2Stomach Neoplasms 2Sarcoma 2Oligodendroglioma 2Neoplasms, Germ Cell and Embryonal 2Liver Neoplasms 2Glioma 2Brain Neoplasms 2Astrocytoma 2Adrenocortical Carcinoma 2Thrombocytopenia 1Teratoma 1Seminoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pelvic Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1

Interventions

Rituximab 17Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15fludarabine phosphate 12Whole-Body Irradiation 11Cyclosporine 10Mycophenolic Acid 9Etoposide 9Methotrexate 8Filgrastim 8Lenalidomide 7Tacrolimus 6Dexamethasone 6Busulfan 6Radiotherapy 5Melphalan 5Cytarabine 5Carboplatin 5Vorinostat 4Thiotepa 4Therapeutics 4Psychiatric Rehabilitation 4Bortezomib 4Antilymphocyte Serum 4Transplantation 3Methylprednisolone 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Dasatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intraocular Lymphoma × sodium thiosulfate × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡